Immupharma plc

Company Information

Address:

50 Broadway
Westminster
London
SW1H 0RG

Tel:

+44 20 7152 4080

Fax:

+44 20 7152 4001

E-Mail:

info@immupharma.com

Secretary:

Tracy Weimar

Registrar:

Company Overview

ImmuPharma is one of the leading specialist drug development companies listed on AIM of the LSE. Our corporate strategy and business model differentiates us from many of their peers. They have UK, French and Swiss operations and have a formal research collaboration with Europe’s largest fundamental research organization in Europe, the Centre National de la Recherche Scientifique (CNRS). ImmuPharma has received to-date $45 million from a corporate deal with a US pharmaceutical company and a number of grants from French government organisations for three of our drug candidates. Their most advanced compound has recently been given the approval from the US FDA to enter phase III with a special protocol assessment and Fast Track designation.

Annual Reports

Description Report Date Published
Annual Report 201231-12-201208-04-2013
Annual Report 201131-12-201126-03-2012
Annual Report 201031-12-201004-04-2011
Annual Report 200931-12-200917-05-2010
Annual Report 200831-12-200823-06-2009
Annual Report 200731-12-200707-05-2008
Annual Report 200631-12-200630-04-2007

Interim Reports

Description Report Date Published

Dividend Histroy

Type Dividend Payment Date
A B C D E F G
H I J K L M
N O P Q R S T
U V W X Y Z #